TULIPS to develop Covid-19 Swabs in India
West Bengal

TULIPS to develop Covid-19 Swabs in India

Agency News

Kolkata, May 19 : Amid calls for increased coronavirus testing nationwide, Suparshva Swabs (TULIPS) today announced that it is currently producing over 2 million COVID-19 SWABS per week, which would increase to over 5 million per week by the end of May 2020, to accelerate COVID-19 testing.

The company is ramping up production, by converting its production lines and reconfiguring equipment, of some of its manufacturing capabilities. It has the largest installed capacity of cotton buds in Asia and possesses capability of taking the COVID-19 swab production to over 30 million swabs per week, if required in due course. TULIPS is the first to develop and receive the ICMR (Indian Council of Medical Research) and NIV (National Institute of Virology) validation for domestically produced ‘polyester’ swabs.

This is significant as COVID Test swabs were not manufactured in India, and were imported from the US or China, claimed the company in a media release. "We developed polyester swabs for COVID testing by converting the 100% cotton processing lines, to produce polyester swabs, within 10 days flat. What is unique here, is that the entire development was done in-house by our amazing team and the trials were done on main production lines, which enabled us to start producing the same day we received the ICMR approval,” Suparshva Swabs' Rahul Jain. (UNI)